XML 21 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities    
Net loss $ (1,408,203) $ (626,682)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of collateral securing employee advances 2,143
Depreciation and amortization 149,553 184,320
Stock-based compensation 327,202 320,366
Gain on settlement of accounts payable (99,774) (111,374)
Amortization of debt discount 15,500 129,767
Changes in operating assets and liabilities:    
Accounts receivable (13,804) 49,259
Inventories (26,768) (38,411)
Prepaid expenses and other current assets (3,858) (21,516)
Accounts payable - trade 527,873 (241,915)
Accounts payable - related parties (862) (83,452)
Accrued expenses and other current liabilities 416,311 (110,786)
Net cash used in operating activities (116,830) (548,281)
Cash flows from investing activities    
Change in restricted cash (98,167) 50,000
Capital expenditures (9,703) (6,331)
Website development costs (13,700) (17,972)
Net cash (used in) provided by investing activities (121,570) 25,697
Cash flows from financing activities    
Principal payments on equipment leases payable (46,143) (64,101)
Proceeds from exercise of common stock options 1,833
Proceeds from issuance of notes payable 358,911 250,000
Repayment of notes payable (50,000) (108,911)
Repayment of notes payable - related parties (33,590) (49,206)
Net cash provided by financing activities 231,011 27,782
Net decrease in cash (7,389) (494,802)
Cash - beginning of period 11,217 506,019
Cash - end of period 3,828 11,217
Supplemental Cash Flow Information:    
Interest paid 95,186 78,489
Non-cash investing and financing activities:    
Issuance of Series B preferred stock for settlement of accrued dividends 319,853 298,918
Cashless exercise of warrants and stock options into common stock 2,647 95
Warrants issued as debt discount in connection with notes payable 15,500 71,400
Accrual of contractual dividends on Series B convertible preferred stock 342,233 319,854
Conversion of accounts payable to notes payable - related party 77,606
Conversion of accounts payable to common stock $ 698,594